Fenwick & West and Wilson Sonsini Goodrich & Rosati represented Metagenomi on the deal. Metagenomi, Inc., a genetic medicines company with a versatile portfolio of next-generation...
Metagenomi’s Collaboration with Moderna
KRAFTON’s Acquisition of Unknown Worlds
Fenwick & West LLP advised Unknown Worlds on the deal, while Kirkland & Ellis advised KRAFTON. Unknown Worlds, the game developer behind Subnautica, announced its definitive agreement...
23andMe Holding Co.’s $400 Million Acquisition of Lemonaid Health
Fenwick & West advised Lemonaid Health on the deal, while Morgan Lewis advised 23andMe Holding. Lemonaid Health, Inc., an on-demand platform for accessing medical care and...
EngageSmart’s $378 Million IPO
Latham & Watkins represented EngageSmart, while Fenwick & West advised the underwriters on the deal. EngageSmart (NYSE: ESMT) announced its initial public offering. The company is a leading...
Limelight’s $55 Million Acquisition of Layer0
Fenwick & West advised Moov Corporation (Layer0) on the deal while Goodwin Procter represented Limelight Networks, Inc. Limelight Networks, Inc. (Nasdaq: LLNW), a leading provider of...
Dynamic Signal’s Merger with SocialChorus
Fenwick & West LLP advised Dynamic Signal on the deal. Dynamic Signal announced its definitive merger agreement with SocialChorus. Both companies are leaders in the digital employee...
Take-Two’s $378 Million Acquisition of Nordeus
Fenwick & West LLP and Arthur Cox advised Nordeus on the deal, while Karanovic & Partners, Hayes solicitors LLP and Harbottle & Lewis advised Take-Two Interactive...